CNBX Pharmaceuticals Market Cap

CNBX Pharmaceuticals has a market cap or net worth of $442.73 thousand as of May 27, 2026. Its market cap has increased by 61.42% in one year.

Market Cap

442.73K

Enterprise Value

1.60M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 442.73K, an increase of 85.98%. That is a compound annual growth rate of 4.22%.

Market Cap History

Date	Market Cap	% Change
May 26, 2026	442.73K	46.95%
Dec 31, 2025	301.28K	30.86%
Dec 31, 2024	230.22K	-47.89%
Dec 29, 2023	441.78K	-81.12%
Dec 30, 2022	2.34M	-79.95%
Dec 31, 2021	11.67M	-58.56%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Altamira Therapeutics	641.73K
Aibotics	617.81K
Exousia Pro	616.53K
Windtree Therapeutics	535.36K
Regenerative Medical Technology Group	478.78K
Lipella Pharmaceuticals	462.08K
Helix BioMedix	402.23K
Actavia Life Sciences	385.91K

Market Cap Rankings